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Ps the Association Between Flow-Mediated Dilation and
ardiovascular Risk Limited to Low-Risk Populations?
aniel R. Witte, MD, PHD,* Jan Westerink, MD,† Eelco J. de Koning, MD, PHD,†‡
olanda van der Graaf, MD, PHD,* Diederick E. Grobbee, MD, PHD,* Michiel L. Bots, MD, PHD*
trecht and Leiden, the Netherlands
OBJECTIVES The aim of this research was to study whether the relation between endothelial function
measured by flow-mediated dilation (FMD) of the brachial artery and cardiovascular risk
factors is affected by the baseline cardiovascular risk.
BACKGROUND Flow-mediated dilation of the brachial artery is widely used as a measure of endothelial
function. Relations between FMD and most cardiovascular risk factors have been described.
METHODS We performed a meta-regression analysis of 211 selected articles (399 populations) reporting
on FMD and cardiovascular risk factors. Mean values of FMD; age; proportion of men;
proportion of smokers; blood pressure; lipids; glucose; and the presence of diabetes mellitus,
of hyperlipidemia, and of hypertension were retrieved from the articles. The 10-year risk of
coronary heart disease (CHD) for each population was estimated based on the Framingham
risk score. The relation between FMD and cardiovascular risk factors was assessed within
each risk category by linear regression analysis, adjusting for age and gender, and weighted for
the study size.
RESULTS A relation between FMD and cardiovascular risk factors was most clear in the category with
lowest baseline risk (below 2.8% per decade). In populations with low baseline risk, for each
% increase in Framingham risk, FMD decreased by 1.42% (95% confidence interval: 0.65 to
2.19). In medium- and high-risk populations, FMD was not related to risk (0.02% [0.27
to 0.22] and 0.06% [0.02 to 0.13], respectively). These findings were independent of
differences in brachial lumen diameter and technical aspects of the FMD measurement.
CONCLUSIONS Only in populations at low risk, endothelial function measured by FMD is related to the
principal cardiovascular risk factors, and to the estimated 10-year risk of CHD. (J Am Coll


























bndothelial dysfunction is recognized as a major factor in
he development of atherosclerosis (1,2). Assessment of
ndothelial function has long been limited by the invasive
ature of measurements. In 1992 Celermajer et al. (3)
roposed a noninvasive method to assess endothelial func-
See page 1994
ion (flow-mediated dilation [FMD]). This measurement
ssesses the brachial artery diameter by ultrasound before
nd after a period of induced ischemia of the forearm.
schemia is induced by inflation of a blood pressure cuff
laced on the distal part of the arm, or on the proximal arm;
MD is generally expressed as the percentage increase in
rachial artery diameter after release of occlusion. This
ilation is mediated by endothelial nitric oxide (NO) release
4) in response to increased shear stress (5). Thus, FMD is
hought to reflect the endothelial NO-mediated regulation
f vascular tone and diameter.
The introduction of FMD opened the possibility of
easuring endothelial function with minimal burden. Ap-
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005, accepted February 8, 2005.lication of it to populations at large and the pivotal role of
ndothelium in early atherogenesis (1) led to great expec-
ations. Flow-mediated dilation was expected to be of use in
isk stratification and in the assessment of the effectiveness
f therapy (6). Although numerous studies showed a rela-
ion between FMD and cardiovascular risk factors (7,8) and
iseased or compromised patients (9–12), evidence for the
rognostic value of FMD was lacking until recently. Mod-
na et al. (13) showed that persistently decreased brachial
ndothelial function relates to a higher incidence of nonfatal
ardiovascular events in hypertensive postmenopausal
omen (based on 32 events). Gökce et al. (14) reported that
rachial artery endothelial function predicts postoperative
vents in patients undergoing vascular surgery (based on 45
vents). Surprisingly, a longer event-free survival was seen
nly in the upper tertile of FMD (8.1%) (14). Previously,
ubenfire et al. (15) reported that the difference in FMD
etween individuals at average risk and those at high risk
as almost three times larger than the difference in FMD
etween those at high risk and patients with clinically
anifest coronary artery disease. These observations could
mply that the relation between brachial artery endothelial
unction and cardiovascular risk is not the same for all
ndividuals but may differ according to baseline risk. To
xplore this concept further, we studied the relation between
rachial artery endothelial function and cardiovascular risk
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earch strategy. Data were obtained from published pa-
ers reporting FMD values. We performed a literature
earch on PubMed. Table 1 shows the four separate queries
hat were used. All queries were limited to “English lan-
uage,” “human study,” and publication date between Jan-
ary 1, 1992, and December 31, 2002. The search was
erformed on January 10, 2003, and yielded 832 hits.
bstracts of these papers were reviewed for “FMD of the
rachial artery by ultrasound imaging,” and 348 papers were
xcluded. The full text copies of the remaining 484 papers
ere retrieved and reviewed. Papers were selected if they at
east reported: mean FMD, expressed as a percentage, with
corresponding standard deviation or standard error; pop-
lation size; and information on cardiovascular risk factors.
election of papers. These criteria led to the exclusion of
73 papers. Twenty reports were excluded because of no
eport on brachial FMD, 10 because of reviews not provid-
ng original data, 3 because of a double report on the same
opulation (the most complete report was included). A
urther 49 reports were excluded due to unclear presentation
f results (multiple ill-defined subgroups, data presented
nly in figures, no standard error or standard deviation for
MD, or FMD not expressed as a percentage), and 191
apers were excluded because they did not provide most of
he required baseline characteristics. Thus, the final set
onsisted of 211 papers (Appendix). If a paper reported on
ore than one population or well-defined population sub-
et, each of these was entered and regarded as a separate
opulation. The 211 selected papers provided data on 399
opulations, which served as the basis for the main analyses.
Abbreviations and Acronyms
CHD  coronary heart disease
FMD  flow-mediated dilation
NO  nitric oxide




#1 “brachial artery” AND (“endothelium”
OR “endothelial”) AND (“function”
OR “dysfunction”)
598
#2 (“FMD” OR “vascular reactivity”)
AND “brachial artery”
257
#3 “flow mediated” AND (“vasodilatation”
OR “vasodilation” OR “dilatation”
OR “dilation”)
521
#4 “endothelium dependent” AND
(“vasodilatation” OR “vasodilation”
OR “dilatation” OR “dilation”)
AND “brachial artery”
407
Combined (#1 OR #2 OR #3 OR #4) 832
ll queries were limited to “English language,” “human study,” and publication datee
etween January 1, 1992 and December 31, 2002.
FMD  flow-mediated dilation.ata entry. For each population, the mean FMD with its
tandard error; the mean nitroglycerin response with its
tandard error; baseline diameter of the brachial artery; the
umber of participants; proportion of males; mean age;
ody mass index; lipids; blood pressure; glucose; and pro-
ortion of participants with diabetes mellitus, hypertension,
r hypercholesterolemia were retrieved from the publication
nd entered into a database by two of the authors (J.W. and
.R.W.). In a subset of the papers (208 populations),
nformation had been extracted on technical aspects relating
o the FMD measurement, including information on type of
quipment (wall track/B-mode), location of the measure-
ent (antecubital fossa/upper arm), occlusion site (upper/
ower arm), occlusion duration (min), and occlusion pres-
ure. This dataset has been used for a separate paper with a
ocus on technical aspects of the FMD measurement as
eterminants of FMD response (16).
issing values. In 171 papers (293 populations), between
ne and three of the variables high-density lipoprotein,
ystolic or diastolic blood pressure, or glucose were not
vailable from the text or tables. Systolic blood pressure was
issing in 108 populations, and diastolic blood pressure in
16 populations. These studies all provided the proportion
f subjects with hypertension. High-density lipoprotein
holesterol was missing in 59 populations, and glucose was
issing in 247 populations. All papers with missing high-
ensity lipoprotein provided the proportion of patients with
yperlipidemia, and all papers with missing glucose values
rovided the proportion of patients with diabetes mellitus.
o avoid the potential problem of underestimating the
ramingham risk score in populations with missing data due
o assignment of the lowest risk category in case of missing
nformation, we estimated the missing values by imputation
ith the “regression imputation method” (17). Based on the
opulations with complete data, four separate linear regres-
ion models were fitted, for systolic blood pressure, diastolic
lood pressure, high-density lipoprotein cholesterol, and
lucose as dependent variables. Independent variables were
roportion of men, proportion of smokers, age, and total
holesterol in all models. The model for high-density
ipoprotein cholesterol, systolic and diastolic blood pressure,
nd glucose also included the proportion of participants
ith hyperlipidemia, hypertension, and diabetes mellitus,
espectively. Additionally, the respective quadratic terms of
he independent variables were also included in the models.
he linear regression models yielded a R2 of 0.41, 0.60,
.42, and 0.79 for high-density lipoprotein cholesterol,
ystolic blood pressure, diastolic blood pressure, and glu-
ose, respectively. Models were used to calculate estimates
or the missing high-density lipoprotein cholesterol, glu-
ose, and systolic and diastolic blood pressure values to
eplace the missing values.
stimation of cardiovascular risk. For each study popu-
ation, the 10-year risk of coronary heart disease (CHD) was
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June 21, 2005:1987–93 Association Between FMD and Cardiovascular Risknstead of the dichotomous categories for gender and
moking, the proportions of men and smokers were used.
nalysis. We used meta-regression techniques (19,20).
et, our approach differs in two ways. Firstly, our outcome
dependent) variable was not a measure of association (e.g.,
n odds ratio), but the mean reported FMD value. Sec-
ndly, we did not aim at estimating a common “true” mean
MD value over all studies. We instead assumed the
xistence of heterogeneity and explored some of the possible
ources of variability between studies. For this reason we
ave chosen a “fixed effects” rather than a “random effects”
odel.
All analyses were weighted according to the inverse
ariance of the FMD measurement: 1/[SE (FMD)]2. Be-
ause in the SE of the FMD the number of subjects is
ncluded, this approach also assigns greater weights to larger
tudies and smaller weights to smaller studies. We first
xplored the relation between FMD and Framingham risk
n a univariate manner with Lowess regression (locally
eighted polynomial regression) and compared a linear
odel with a model including a quadratic term for Fra-
ingham risk. Populations were then categorized according
o tertiles of Framingham risk score (cutoff points were
core of 2.8 and 9.5). Within each risk category (low,
edium, and high risk), the relation between FMD and
ndividual risk factors was explored by linear regression,
djusting for age and gender, and weighted by study size.
he presence of effect modification of these relations by
able 2. Patient Characteristics of the Studied Populations, by T
n Lo
ales (%) 399 46.8
ean age (yrs) 399 30.4
ody mass index (kg/m2) 250 23.6
otal cholesterol (mmol/l) 399 4.9
DL cholesterol (mmol/l) 291 3.0
DL cholesterol (mmol/l)* 399 1.4
riglycerides (mmol/l) 320 1.0
lucose (mmol/l)* 399 5.7
bA1c (%) 59 7.7
omocysteine (mol/l) 43 9.9
ystolic blood pressure (mm Hg)* 399 116.8
iastolic blood pressure (mm Hg)* 399 71.0
eart rate (beats/min) 120 69.1
urrent smokers (%) 399 11.0
iabetes mellitus (%) 379 13.0
yperlipidemia (%) 271 3.8
ypertension (%) 336 0.1
oronary artery disease (%) 284 0.0
MD (% increase of baseline diameter) 399 6.8
TG (% increase of baseline diameter) 305 17.1
aseline diameter (mm) 333 3.5
aseline brachial artery flow (ml/min) 143 91.8
eactive hyperemia (% of baseline flow) 190 522.3
ramingham risk score (% risk/10 yrs) 399 1.1
alues are means (SD). *Values for high-density lipoprotein (HDL) cholesterol, glu
FMD  flow-mediated dilation; LDL  low-density lipoprotein; NTG  nitroardiovascular risk was tested by linear regression in the oresence of a multiplicative interaction term. Similar anal-
ses were performed for the nitroglycerine response.
ESULTS
he 399 populations included in our analyses reported on
1,984 patients. Population size varied from 5 to 654
median 20). General characteristics by category of Fra-
ingham risk are presented in Table 2. The Lowess
egression line (Fig. 1) shows how the local regression line
hanges with changing baseline risk. A linear regression
odel of the relation between Framingham risk (indepen-
ent) and FMD (dependent), including a quadratic and a
ubic term for Framingham risk, yielded the following
quation:
FMD(%) 7.226 0.4170 · FR 0.0195 · FR2 0.0003 · FR3
ll terms were statistically significant (p  0.001, p 
.012, and p  0.046 for the linear, quadratic, and cubic
erms, respectively). This regression line shows an initial
teep negative slope, which gradually changes towards a flat
ine as risk increases. In other words, with increasing risk,
he magnitude of the relation between FMD and risk
radually attenuates. The coefficients did not materially
hange in magnitude nor direction and significance when
djustments were made for baseline lumen diameter, for
ocation of the occlusion cuff (upper arm/lower arm), or for
s of Framingham Risk
Tertiles of Framingham Risk Score
sk Medium-Risk High-Risk
30.0 55.5 33.7 78.4 15.8
6.5 50.6 8.3 57.5 4.0
2.5 24.5 2.0 25.8 2.3
0.7 5.4 0.7 5.0 0.7
0.8 3.4 0.6 3.1 0.7
0.1 1.4 0.2 1.1 0.2
0.3 1.5 0.6 1.8 0.5
1.7 5.1 0.6 5.7 1.1
1.9 5.1 0.7 6.4 1.5
3.0 12.2 7.3 11.0 1.5
4.6 123.8 7.0 129.7 5.8
4.9 77.0 4.6 77.4 3.7
5.3 66.9 5.6 61.8 3.4
23.1 19.3 23.9 29.7 27.9
33.7 1.8 12.4 13.1 24.1
19.1 7.5 20.5 31.4 32.3
0.7 5.9 17.1 34.6 20.1
0.0 5.5 21.1 68.6 45.9
3.5 5.4 2.7 4.5 2.1
3.7 16.0 3.2 14.9 3.5
0.5 4.0 0.6 4.3 0.3
60.9 184.2 81.1 128.4 78.0
224.1 398.0 133.4 336.4 130.3
0.8 6.6 1.9 13.5 4.7
ystolic and diastolic blood pressure include imputed values.
n.ertile


































































1990 Witte et al. JACC Vol. 45, No. 12, 2005
Association Between FMD and Cardiovascular Risk June 21, 2005:1987–93echnical aspects were not statistically significant. This
mplies that the relation of FMD and Framingham risk
core in subjects with an upper arm cuff position was similar
o the relation found in subjects with a lower arm cuff
osition. However, when year of publication was taken into
ccount as a means to further adjust for between-study
ifferences, the p value of the cubic term attenuated to 0.11.
Given the importance of cuff location and the fact that
1% of the studies used lower arm occlusion, we analyzed
he data in that group separately based on data from 169
tudies despite the absence of a statistically significant
nteraction term. The regression coefficients of the model
ere:
FMD(%) 6.453 0.369 · FR 0.021 · FR2 0.00035 · FR3
he statistical significance of the parameters were p 
.007, p  0.047, and p  0.082 for the linear, quadratic,
nd cubic terms, respectively. This regression line looks
imilar to the earlier one in that it shows an initial negative
lope, which gradually changes towards a flat line as risk
ncreases. The analysis among populations with upper arm
cclusion (n  39) showed a formula of FMD(%) 
4.246  1.518 · FR  0.001 · FR2  0.000024 · FR3 with
tatistical significance values of p  0.03, p  021, and p 
.46. This subgroup analysis, with very limited power and,
hus, limited precision for detecting trends different than
inear trends, indicated a linear decline in FMD with
ncreasing Framingham risk score.
Figure 2 shows that a significant inverse relation between
he Framingham risk score and FMD is only present when
isk score is below three points. No changes were seen when
he model was additionally adjusted for baseline lumen
igure 1. Plot of the mean flow-mediated dilation (FMD) of the
rachial artery by mean Framingham risk estimate for each of the study
opulations. Line is the Lowess regression line. Points are weighted
ccording to the inverse variance of FMD for each study [1/SE
FMD)2]. Tertiles of Framingham risk cutoff points were 2.8% and
.5%.iameter, for location of the occlusion cuff, or occlusion
d
wime. When year of publication was taken into account, the
ignificance and magnitude of the relations was not altered.
The relation between cardiovascular risk factors and the
ean FMD value within each cardiovascular risk category is
isplayed in Table 3. In populations at low risk, an inverse
elation with FMD is clearly present for most cardiovascular
isk factors. In populations at intermediate or high risk,
ost relations are of a lower magnitude or absent. The last
olumn shows the p values for the multiplicative interaction
erms. Significant interaction was present for age, total
holesterol, low-density lipoprotein cholesterol, glucose,
nd proportion of smokers, indicating that, for these vari-
bles, the relation with FMD was significantly different
cross the three strata of risk.
The results for nitroglycerine response were similar to the
ndings for FMD:
NTG(%) 10.84 1.241 · FR 0.07 · FR2 0.001 · FR3
ll terms were statistically significant (p  0.001, p 
.001, and p  0.008 for the linear, quadratic, and cubic
erms, respectively). The relations of Framingham risk score
ith nitroglycerine in tertiles of risk score showed a strong
nverse relation among the low-risk group, and less strong
elations for the middle- and upper-risk score tertiles. The
egression coefficients reflecting change in nitroglycerine
esponse with one point increase in Framingham risk score
ere 4.31% (95% confidence interval 5.72 to 2.90),
.07% (0.42 to 0.55), and 0.31% (0.41 to 0.21),
espectively.
ISCUSSION
ur analysis showed that endothelial function, as measured
y FMD, is related to the principal cardiovascular risk
actors, and to the estimated 10-year risk of CHD predom-
igure 2. The association between Framingham risk and flow-mediated
ilation (FMD) of the brachial artery within tertiles of Framingham risk,
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June 21, 2005:1987–93 Association Between FMD and Cardiovascular Risknantly in populations with a low baseline risk. A similar
nding was observed for the nitroglycerine response.
Before we accept our findings, a number of issues need to
e addressed. First, we performed meta-regression analysis
o explore baseline risk as a source of heterogeneity in the
elation between FMD and cardiovascular risk factors across
ifferent populations. The most important advantage of our
pproach is that it enables investigation of the relation
etween FMD and risk across a far wider range of risk than
ould be possible within one single study. Most studies
eporting on FMD examine a very limited number (median
0) of highly selected patients. As a consequence, the
ariation in baseline cardiovascular risk within each popu-
ation is small. In order to obtain the wide range of baseline
isk required to address our research question, we have
ompiled a population of study populations. In most meta-
nalyses, the aim is to summarize a measure of effect into
ne single estimate of the “true” effect. In such a situation,
eterogeneity between studies is a potential source of bias
hat needs to be minimized. In our case, however, virtually
one of the existing studies reported an estimate of the
elation between FMD and cardiovascular risk. We have,
herefore, chosen to study this relation based on the varia-
ion in FMD and cardiovascular risk between studies.
onsequently, our aim was not to estimate one single “true”
ean FMD, but to explain the variation in FMD by the
ariation in cardiovascular risk. Second, because informa-
ion on some risk factor variables could not be extracted
rom a large number of papers, the missing values were
mputed. There is ample evidence indicating that imputa-
ion of missing values is preferable over analysis of fully
nformative cases only (16), the latter leading to biased
esults. We have imputed only the missing values of the
ariables needed to calculate the Framingham risk score,
hereby avoiding the underestimation of risk in populations
ith missing values that would have occurred had we




ales (per 10%) 399 0.35 0.55; 0.15
ge (per decade) 399 0.60 1.52; 0.32
MI (per kg/m2) 250 0.24 0.50; 0.02
otal cholesterol (mmol/l) 399 1.36 2.18; 0.53
DL cholesterol (mmol/l) 291 1.36 2.31; 0.40
DL cholesterol (mmol/l) 399 1.43 5.89; 3.04
riglycerides (mmol/l) 320 1.81 4.27; 0.65
lucose (mmol/l) 399 0.64 0.99; 0.29
bA1c (%) 59 1.13 1.73; 0.53
omocysteine (mol/l) 43 1.00 2.18; 0.19
ystolic BP (per 10 mm Hg) 399 0.65 2.11; 0.81
iastolic BP (per 10 mm Hg) 399 1.94 3.37; 0.50
mokers (per 10%) 399 0.26 0.51; 0.00
egression coefficients are weighted according to the inverse variance of flow-medi
oefficients for gender and age are adjusted for the other. n indicates the number of p
isk factor and risk score as continuous variables.
BMI  body mass index; BP  blood pressure; CI  confidence interval; HDLalculated the Framingham risk score without prior impu- pation. Third, when making inferences, results may be a
onsequence of confounding. We have dealt with this issue
y adjusting our analyses for the mean age and the gender of
ach population in the analyses of separate risk factors.
oreover, adjustment for details of the FMD study proto-
ol did not alter our principal findings. Finally, it should be
oted that comparison of the results of the within-tertile
nalyses might be hampered by differences in risk factor
istribution between the tertiles, and with that a different a
riori power to detect a relationship with FMD in a
tratum.
Our main finding (i.e., the absence of a relation between
MD and cardiovascular risk in populations at medium and
igh risk) could be explained in two distinct ways. First is
hat the observations are the result of a biological phenom-
non. Damage to the endothelium and the resulting endo-
helial dysfunction is thought to be one of the initial steps in
therogenesis (1,21,22). It is conceivable that the ability of
ndothelium to produce NO in response to stimuli like
hear stress is affected at an early stage in this process and
hat beyond this point additional increase in risk factors
oes not cause an additional decline of function. According
o this view, other measures of endothelial function such as
dhesion molecules (intracellular adhesion molecule
ICAM-1], vascular cell adhesion molecule [VCAM-1],
-selectin) or invasive measures of endothelial function
hould yield similar results. Although no similar meta-
nalyses exist for other measures of endothelial function,
ircumstantial evidence suggests that there is a continuous
elation in populations at high risk. A meta-analysis of
erum markers of endothelial function (ICAM and
CAM), based on generally healthy populations (23),
howed a relation with cardiovascular risk, but did not
xamine this relation separately in categories of increasing
isk. Invasive measures of endothelial function with a
isk Factors, by Tertiles of Cardiovascular Risk
Medium-Risk High-Risk
p(int) 95% CI  95% CI
0.08 0.24; 0.07 0.14 0.38; 0.10 0.09
0.49 0.15; 1.12 0.51 0.45; 1.46 0.00
0.04 0.28; 0.36 0.38 0.53; 0.23 0.15
0.83 1.48; 0.19 0.53 0.03; 1.09 0.01
0.75 1.72; 0.22 0.47 0.20; 1.13 0.01
0.13 2.84; 2.57 3.19 1.03; 5.36 0.56
1.12 1.93; 0.31 0.16 0.75; 1.07 0.57
0.06 0.90; 0.78 0.05 0.38; 0.29 0.03
0.28 1.93; 1.37 0.69 1.47; 0.09 0.23
0.03 0.17; 0.11 0.14 0.72; 0.45 0.78
0.41 1.06; 0.24 1.23 1.83; 0.63 0.09
0.22 1.24; 0.80 0.78 1.77; 0.20 0.08
0.14 0.34; 0.06 0.08 0.21; 0.05 0.01
ilation for each study [1/SE(FMD)2] and adjusted for age and gender. Regression
ons included. p(int) indicates the p value of the multiplicative interaction term using
h-density lipoprotein; LDL  low-density lipoprotein.lar R
ated d
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Association Between FMD and Cardiovascular Risk June 21, 2005:1987–93rospective cardiovascular risk (24,25) in patients at me-
ium or high risk.
A second possible explanation might be that the accuracy
f ultrasonographic assessment of FMD as a measure of
ndothelial function is hampered in subjects with increased
isk. More specifically, vessels, including the brachial artery,
re known to become progressively stiffer with age and
ncreasing cardiovascular risk factors (26). If arterial stiffness
oses a physical limit to the ability of the brachial artery to
ilate, even in the presence of functional endothelium, this
ould mean that, in high-risk patients (with stiffer arteries),
MD is no longer a reflection of endothelial NO-related
echanisms, but is distorted by stiffness and may become
ifficult to interpret. Our findings on nitroglycerine values
upport this notion. In addition, we have previously ob-
erved in a population of high-risk patients that the relation
etween FMD and age and smoking was present only in
atients with relatively preserved distensibility of the bra-
hial artery (27). Furthermore, the lack of a relation between
he Framingham risk score and FMD in those at high risk
f cardiovascular disease as found in our study may indicate
hat, indeed, in high-risk patients, the measured FMD
ight not reflect endothelial function completely.
In contrast with our findings may be the observations by
ökce et al. (14) who showed in a very high-risk group that
ndothelial dysfunction does relate to an increased risk of
ardiovascular events. A longer event-free survival was only
bserved in the upper tertile of FMD (8.1%), whereas
iddle and low tertiles of FMD showed no difference in
vent-free survival (14). Based on the earlier mentioned
rguments, it may be that the described risk relations reflect
nother process than endothelial function per se. Please note
hat the relationship with patient-averages across studies
ay not be the same as the relationship for patients within
rials (20). This means that our findings do not exclude the
ossibility that a relation may be found within a high-risk
opulation. Furthermore, our principal finding pertains to
he different nature of the relationship across categories of
isk rather than to the presence of a relation per se. Results
rom the Framingham Heart study indicated a graded
nverse relation of FMD with Framingham risk score in
ubjects without prevalent cardiovascular disease (28). The
ramingham risk was presented in quintiles rather than in
bsolute scores, and age was not used in the calculation of
he Framingham risk. Because this population comprises
ealthy community volunteers, it might be that the finding
n the paper by Benjamin et al. (28) reflects the left part of
igure 1, (i.e., subjects with relatively low risk). If so, the
raded association of FMD with Framingham risk agrees
ith our hypothesis.
Flow-mediated dilation is currently used in an increasing
umber of studies as a measure of endothelial function. It
as been suggested that FMD may help in risk stratifica-
ion, and the utility of FMD measurements in randomized
ontrolled trials as primary outcome as an alternative for
ardiovascular events has been suggested. The latter notions based on the evidence that endothelial dysfunction is
elated to unfavorable levels of cardiovascular risk factors, to
resence of vascular damage, and to future risk of cardio-
ascular disease. Moreover, it is assumed that FMD is an
qually accurate measure of endothelial function both in
ealthy individuals and in patients with advanced athero-
clerosis. Although we did not study whether endothelial
ysfunction predicts future cardiovascular events, the find-
ngs may indicate that, indeed, in high-risk patients, the
easured FMD might not reflect endothelial function
ompletely.
In conclusion, our analyses show that, only in populations
t low risk, endothelial function measured by FMD is
elated to the principal cardiovascular risk factors, and to the
stimated 10-year risk of CHD.
eprint requests and correspondence: Dr. Michiel L. Bots,
ulius Center for Health Sciences and Primary Care, Stratenum
.131., University Medical Center Utrecht, Heidelberglaan 100,
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